CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
CDK4/6抑制剂通过刺激AP-1转录活性来重编程乳腺癌增强子图谱。
期刊:Nature Cancer
影响因子:23.5
doi:10.1038/s43018-020-00135-y
April C Watt # ,Paloma Cejas # ,Molly J DeCristo # ,Otto Metzger-Filho ,Enid Y N Lam ,Xintao Qiu ,Haley BrinJones ,Nikolas Kesten ,Rhiannon Coulson ,Alba Font-Tello ,Klothilda Lim ,Raga Vadhi ,Veerle W Daniels ,Joan Montero ,Len Taing ,Clifford A Meyer ,Omer Gilan ,Charles C Bell ,Keegan D Korthauer ,Claudia Giambartolomei ,Bogdan Pasaniuc ,Ji-Heui Seo ,Matthew L Freedman ,Cynthia Ma ,Matthew J Ellis ,Ian Krop ,Eric Winer ,Anthony Letai ,Myles Brown ,Mark A Dawson ,Henry W Long ,Jean J Zhao ,Shom Goel